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Despite advances in medicine and improvement in living conditions pneumonia is still a
common disease in the community. It has been estimated that 6 million individuals
annually develop pneumonia.l In the United Kingdom and United States it is still the fifth
to sixth leading cause of death, and the most common cause of infectious disease causing
death.l-3 A higher incidence of community-acquired pneumonia is found in children aged
under 2 years, in persons 65 years of age and older, in individuals with an impaired host
defense and in patients with chronic illness(es). In the Westem \ilorld, only lO% to 25 7o
of patients with community-acquired pneumonia will be admitted to a hospital.2'3 The
majority of the pneumonias will be treated at home by a general practitioner.
S pneumoniae remains the most common cause of community-acquired pneumonia. In
prospective studies pneumococci were bacteriologically identified in approximately one
third of the hospitalized patients.a-o Other pathogens such as M pneumoniae, Chlamydia
spp., Legionella pneumophila and Coxiella burnetii are the cause in llVo Ío 20Vo of the
cases, viruses in lOVo, and non-pneumococcal bacteria including Gram-negatives in only
57o. T\e aetiologic diagnosis of community-acquired pneumonia is not established in
approximately 307o to 40Vo of the patients.T
Accurate diagnosis of community-acquired pneumonia is not only complicated by
antibiotic treatment prior to hospitalization, the absence of sputum, and difficulties in
serological testing, but is also dependent on the ability to recognize new pathogens and by
unusual microorganisms infecting normal and immunocompromised patients. Clinical
symptoms and signs, laboratory tests, and chest radiographs may indicate a specific type
of pneumonia, but there is a great overlap in features between the different causative
microorganisms. Typical pneumococcal pneumonia is characterized by leucocytosis with
a shift to the left, a lobar infiltrate and a rapid decline of fever to a normal body tempera-
ture level after initiation of adequate antibiotic treatment.
The extensive use of antibiotics for respiratory infections leads to an inability to detect
the causative agent(s) and the possibility of inaccurate interpretation of culture results.
Antimicrobial drugs with a broad-spectrum or a new mode of action may invite empiric
administration without making an accurate diagnosis. In a later phase of the illness, when
the pneumonia doesn't get better or even deteriorates despite antibiotic therapy, diagnos-
tic and therapeutic problems occur. In these cases, invasive techniques are justified in
order to identify the causative agent(s) of pneumonia (Chapter 1).
Pneumococci are generally susceptible to penicillin in many European countries in-
cluding the Netherlands. Therefore, it is not surprising that after initiation of antibiotic
therapy clinical specimens from patients with community-acquired pneumonia do not
yield pneumococci on culture. The specific diagnosis can therefore often not be assessed.
One approach to increasing the number of diagnoses of pneumococcal infections is to
detect pneumococcal antigens in body fluids. Immunological tests for pneumococcal
antigen detection do not depend on viable pneumococci, and may also yield results in
deficiently processed- or collected specimens.
Due to continuous proliferation of pneumococci in the presence or absence of anti-
biotics capsular polysaccharides and C-polysaccharides (pneumococcal-specific cell wall
component) are released into the lung tissue. The means by which antigen is cleared is
only paÍially known, but is probably due to mucociliary transport, coughing, phago-
cytosis, and resorption into serum either as pure antigen or as circulating immune com-
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plexes subsequently excreted as intact or partially degraded antigen. Different methods
have been developed to detect pneumococcal antigen in specimens including sputum.
serum. and urine.
For the current study latex agglutination (LA, Wellcog en S pneunnniae kit) was chosen
because of its simplicity and speed in providing a result (within 30 minutes); important
Íactors in clinical practice.
ln Chapter 2 results of the value of antigen detection in clinical specimens (sputum,
blood, urine and pleural f luid) in patients with community-acquired pneumonia re given.
Sputum specimens were considered suitable Íbr the study only if cytological examination
by Gram-stain smear yielded a leucocyte/squamous epithelial cell ratio of > 10 (magnifi-
cation x 100). The specimens which fulfilled this criterium were defined as representative
of the lower respiratory tract. We chose this ratio for logistic reasons; generally a ratio > -5
or criteria of > 25 leucocytes and < 10 squamous epithelial cells are used.8p
Pneumococcal antigen, determined in definite (positive blood culture) and probable
pneumococcal pneumonia, was detected by LA in first day (representative) sputum
specimens with a sensitivity of 941o. In 23 (85E;) of 27 patients antigen was detected in
the Íirst available representative sputum.
In sputum from patients with a pneumonia of other known aetiology and lung infarc-
tion a specificity of 8Jo/o was determined. The value of antigen detection was especially
emphasized in patients who would otherwise have been diagnosed as pneumonia of
unknown aetiology; in 12 (48o/o) of these 25 patients antigen could be detected.
In patients with pneumococcal pneumonia as well as in those with pneumonia of unknown
aetiology antigen could also be detected for one week or even longer in sputum specimetrs
during follow-up under adequate antibiotic therapy (Chapter 3).
However, after two days of antibiotic treatment hardly any pneumococci were
detected by Gram-stain smear and culture. ln addition, antigen detection in representative
sputa was compared to non-representative sputa on admission and during follow-up. The
same trend of antigen persistence was observed for both types of specimen in the pneumo-
coccal pneumonia patients and in the group of pneumonia of unknown aetiology. The high
specificity of the test was confirmed during follow-up in both representative and non-
representative sputum specimens collected in the pneumonia of other known aetiology
group. It seems that sputa not suitable for conventional microbiological examination can
reliably be used for pneumococcal antigen deÍection.
In addition, it has to be emphasized that detectable antigen in lower respiratory tract
secretions is not specific for the presence of pneumococcal pneumonia. Patients with
chronic bronchitis but without pneumonia may have detectable antigen in sputum.
especially if the lower respiratory tract harbours pneumococci.l0 12 When these patients
present with pneumonia, detectable antigen in sputum cannot discriminate between
colonisation and acute infection. As stated by Schmid and coworkersl3 detectable antigen
may differentiate pneumococcal pneumonia Íiom non-pneumococcal pneumonia, rather
than from chronic bronchitis or other pneumococcal cariers.
The value of sputum examination Íbr establishing the aetiologic diagnosis of bacterial
pneumonia has been widely discussed. Colonisation of the upper respiratory tract by
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potential pathogens, such as S pneumoniae, H influenzae, M catarrhalis, S aureus, Gram-
negative bacteria and anaerobes may contaminate sputum, resulting in less reliable
interpretation oflaboratory results. Therefore the sputum wash technique was introduced
in order to reduce these oropharyngeal contaminants and to facilitate sputum examina-
1l6n.la'15 Theoretically, sputum washing may also reduce the amount of pneumococcal
antigen present.
However, in Chapter 4 it is demonstrated that washing of sputum has no deleterious
effect on the detection of pneumococcal antigen. No significant difference in the rate of
detection was found between washed and unwashed specimens. Remarkable was the low
frequency of "only unwashed antigen positive specimens", which indicates that the anti-
gen content in oropharyngeal secretions originating from pneumococci and/or cross-
reacting microorganismens is only a minor disturbing factor. In none of the in parallel
investigated specimens could antigen be detected in the washed poÍion, but not in the
unwashed portion.
The results of antigen detection in serum as described in Chapter 2 were very disappoint-
ing. In only 3 of 14 patients with pneumococcal bacteraemia ntigen was detected by LA:
non-bacteraemic patients yielded no positive results. This confirms the poor results found
in other studies.l6 Serum yielded detectable antigen for several days in only one patient
with bacteraemic pneumococcal pneumonia. A reason for this may be ,nu, u, t"ur, 100/ml
pneumococci are required for antigen to be detectable, and in bacteraemic cases the
concentration of pneumococci n blood is typically far below this detection level.
During pneumonia pneumococcal polysaccharides are excreted in urine in large
quantities.lT Therefore urine would seem to be an ideal aid in diagnosing pneumococcal
pneumonia. In Chapters 2 and 5 the results of pneumococcal antigen detection in urine
specimens from different patient groups are reported. Pneumococcal polysaccharide in
urine has been detected by LA and CIEr8,re and by CoA and ELISA.Ie As in the study by
Ajello et a1.20, we found LA to be inefficient. In only one patient with pneumococcal
pneumonia could antigen be detected in urine, but this could also have been a false
positive reaction due to the presence of a cross-reacting C albicans which was present in
the urine of this patient.
Concentration of urine specimens, maximally 300-fold, did not lead to more positive
results. No difference in antigen results was demonstrated in a subgroup of urine speci-
mens tested with another LA test (Slidex Pneumo-kit). Reasons for insensitivity of the LA
tests in urine specimens remain unclear. It has been suggested that a change in physico-
chemical properties of pneumococcal polysaccharides, the unfavourable microenviron-
ment (pH, salt and protein concentrations) of urine, and limited antigen concentration are
possible explanations. u,1e'21
Parapneumonic effusion is associated with acute bacterial pneumonia in approximately
40 to 60 percent of the patients.22-24 Pletrral fluid is a result of the increased permeability
of the visceral pleura due to inflammation.
During the course of pneumococcal pneumonia there is a constant replenishment of
antigens from the pulmonary infiltrate to the accumulated pleural fluid. Therefore, pleural
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fluid, which can be obtained under sterile conditions, seems to be an ideal biological fluid
for bacteriological examination as well as for antigen detection. Pleural fluid from our
patients was examined only if empyema was suspected or the aetiologic diagnosis was not
established (Chapter 6). Pleural fluid from 33 (247o) of the 135 included pneumonia
patients was examined. LA detected antigen with a sensitivity of 897o in the pneumo-
coccal pneumonia group. Pneumococci were microbiologically identified in pleural fluid
in only 2 of 9 of these patients.
Pleural fluid from patients with pneumonia of other known aetiology was also inves-
tigated, yielding a specificity of 92Vo.In addition, antigen was present in pleural fluid
from 7 of 12 patients with pneumonia of unknown aetiology. In these patients a
pneumococcal aetiology could be definitely assumed. Antigen persistence for more than
one week was found in patients who had an empyema. Similar results were reported in
other studies2s,2ó using the CIE technique; in both children and adults antigen was
detected with a high sensitivity. However, CIE is a less simple and more time-consuming
test to perform than LA, and detects pneumococcal types I and 14less effectively.2T
In order to investigate whether the quantity of bacterial antigens in clinical specimens may
be a determining factor for antigen detection, an in vitro experiment was set up to assess
the exact number of pneumococci that is required for a positive antigen result by LA
(Chapter 7). Suspensions of pneumococci originating from different clinical specimens
were diluted serially. One part was investigated for the presence of pneumococcal antigen,
and the other was used for quantitative cultures. It was observed that pneumococcal
antigen was detected by LA only when the concentration of 10e to 102 microorganisms
per ml was exceeded. No difference in threshold concentration was demonstrated in the
differently tested capsular types. This was confirmed in another experiment using growth
curves (Chapter 7). The same concentration of pneumococci was required for antigen to
be detectable by LA. In addition it was demonstrated that once antigen could be detected,
it remained detectable for the entire'72 h of the experiment, even when the concentration
of viable pneumococci fell below the threshold concentration of 100 to 107 micro-
organismens per ml and even in the total absence of viable pneumococci. This observation
of antigen persistence in the absence of viable pneumococci is in agreement with the
results found in sputum and pleural fluid.
The threshold concentration of pneumococci required for a positive LA is comparable
to that found by other mglhqdsa'28-30, although ELISA seems to be slightly more sensitivg
than the other tests.l9,3l
It is known that the number of pneumococci present in body fluids bears a good
relation to the severity of the pneumonia and the prognosis of the patient.32,33 In sputum
from patients with pneumococcal pneumonia pneumococci are often cultured in a number
exceeding 107 per ml.3a Pneumococci are probably present in lower concentrations in the
upper respiratory tract of pneumococcal carriers and in sputum of patients with chronic
bronchitis.3s'36 It is worth noting that the number of pneumococci that are required for
clinical symptoms of infection to appear, is probably equal to the number required for a
positive LA reaction.
The influence of penicillin on viable pneumococci during growth is enormous (Chap-
ter 8). Only if the threshold concentration of approximately 100 to 10r pneumococci per
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ml had been reached, could antigen be detected. Whether penicillin was added to the tubes
with bacteria at 0 hours or 8 hours had no influence on antigen detection during the growth
curves. Only those pneumococci which had had the opportunity of growing to the
threshold concentration before penicillin was added, yielded detectable antigen, which
remained detectable for the entire 72 hours of the experiment. In contrast to what one may
expect, penicillin added to the pneumococci when they were at a concentration just below
the threshold level had no influence on antigen detection.
Although the in vitro situation cannot be compared with that present in vivo, bacterial
concentrations of more ,nun 160/ml occur in humans. It has been reported that higher
threshold concentrations ofbacteria are needed in vitro than in vivo for a positive antigen
test result.a In addition, in vivo antigen is probably synthesized or released in higher
concentrations than in vitro.a
The number of bacteria present in the lower respiratory tract is dependent on several
factors such as mucociliary clearance, phagocytosis, immunologic reactions, and anti-
biotic therapy. When in spite of negative cultures antigen persists, it means that the thres-
hold value for antigen detection is still valid, and sufficient antigen is available.
It has been suggested that pneumococcal colonisation of the oropharynx may interfere
with antigen detection in lower respiratory tract secretions.l6'37 However, the question
whether antigen can be detected in specimens from individuals colonized with pneumo-
cocci has not been determined. To assess this potentially misleading factor in the diagno-
sis of pneumococcal pneumonia, upper respiratory tract secretions from patients with a
potentially high carrier rate (COPD and asthma patients), were cultured and tested for the
presence of pneumococcal antigen by LA (Chapter 9). Pneumococci were most frequent-
ly (29Vo) isolated from the oropharynx, whereas the nasopharynx and saliva yielded
positive cultures in 8Vo md l6Vo of the patients respectively. In only 4 (gEa) of 46 oro-
pharyngeal specimens from which pneumococci were isolated, could antigen be detected
by LA. Quantitative cultures of the oropharynx, performed in a sub-group of pneumo-
coccal carriers, yielded pneumococcal concentrations of 10: to l(F per ml, which is far
below the threshold level (100 -102 CFU/ml) required for antigen to be detectable. In non-
pneumococcal carriers antigen was detected in the oropharynx in the same proportion
(87o) as in pneumococcal carriers. These positive antigen results may be explained either
by cross-reactions with other Streptococcus species from that area or by pneumococcal
antigen originating from the lower respiratory tract.
The high number of antigen positive saliva specimens, in the absence of viable
pneumococci, is probably due to cross-reactions of aerobic and anaerobic streptococci
present in concentrations exceeding l0z to 108 bacteria per m1.38-40 Antigen present in
saliva probably seldom influences antigen detection in sputum, because only tenacious
material is used for sputum examination, and saliva is washed away by using the wash
technique. This assumption is confirmed by the results noted in Chapter 4, in which, by
comparing washed and unwashed sputum specimens, a low frequency of "only unwashed
antigen positive specimens" was found.
The effect ofpneumococcal carriership on antigen detection has been studied only in
pneumococcal carriers with colds (acute coryzal infection).41 Antigen could not be
detected in any of these individuals by CIE in respiratory tract secretions. The authors
concluded that detection of antigen in respiratory tract secretions indicates infection
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caused by S pneumoniae. It should be emphasized that this conclusion is not always
applicable to patients with chronic bronchitis, since antigen can be detected in their sputa
during stable periods without an exacerbation of the dissass.10'11'13
Pneumococcal pneumonia develops when pneumococci colonizing the upper respiratory
tract are aspirated into the terminal airways of the lung(s).42 In these patients an increased
pneumococcal carrier state of the upper respiratory tract has been observed.43'44 fhere-
fore, some studies have suggested that the isolation of pneumococci from the nasopharynx
and oropharynx may be of supplemental value in diagnosing pneumococcal pneu-
monia.45'46 As already shown, during antibiotic treatment cultures for pneumococci
become negative more rapidly than tests for antigen detection. Therefore, detectable
antigen in the oropharynx may also provide an assignment for aetiology, especially in
patients who cannot expectorate sputum. In order to confirm this hypothesis, we exa-
mined oropharyngeal secretions from different patient categories and from healthy
individuals (Chapter L0). It was found that the rate of antigen positive specimens gradu-
ally increases with the severity of pneumococcal carriership or infection (healthy individ-
uals, COPD or asthma, LRTI, pneumonia). Antigen was detected in the oropharynx in 8
(387o) of 2l patients with pneumococcal pneumonia, whereas patients with LRTI and
carriers yielded positive results in 207o and 97o respectively. No false positive reactions
were observed in healthy individuals, suggesting that cross-reactions with other bacteria
(e.g. c-haemolytic streptococci) are irrelevant for pneumococcal antigen detection in this
area, In contrast 1s s1hs1sa3-46 a relatively low pneumococcal isolation rate (14Vo) was
established in the upper respiratory tract of patients with pneumococcal pneumonia. This
might be explained by the different method that was used.
In our opinion detectable antigen in oropharyngeal secretions originates from the
lower respiratory tract. During coughing aerosolized droplets of lower respiratory tract
secretions are deposited on the oropharynx. Most of the respiratory tract secretions are
transported to the oropharynx by mucociliary action. Impaired laryngeal-pharyngeal
function, especially in critically ill patients, may lead to stasis of these secretions. The
assumption that oropharyngeal antigen originates from the lower respiratory tract was
provided by the observation that antigen was detected in the oropharynx of patients with
pneumonia of unknown aetiology. Another aÍgument for this assumption was provided in
patients with pneumococcal pneumonia; antigen detection yielded concordant results in
sputum and oropharyngeal specimens collected on the same day.
Although the sensitivity (approximately 40Vo) of LA in detecting antigen in oro-
pharyngeal secretions from patients with pneumococcal pneumonia is much lower than
that found in sputum (95Vo), the simplicity of obtaining a specimen promotes this method
for supplemental application, especially when sputum is not being produced.
The case repoÍs in Chapter 11 illustrate the application and usefulness of antigen detec-
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Conclusions
l . Pneumococcal capsular antigen detection in clinical specimens, using latex agglutina-
tion (LA), is of diagnostic value in patients with community-acquired pneumonia. In
sputum (preferably representative specimens) and in pleural fluid antigen determina-
tion is of important value in addition to Gram staining and culture for the diagnosis of
pneumococcal pneumonia. Antigen detection in urine and serum appears to have
limited utility for diagnosing pneumococcal pneumonia.
Pneumococcal antigen remains detectable in sputum or pleural fluid even after Gram
stain and culture become negative. Therefore, the number of patients diagnosed as
pneumococcal pneumonia, who would otherwise be classified as unknown aetiology,
will be increased. Some restrictions should be kept in mind for patients with chronic
bronchitis, since detectable antigen in sputum could also be found in the absence of
pneumonia.
The sputum wash technique, which has been developed to reduce contaminating oro-
pharyngeal flora while potential pathogens are not affected, has only a minor influence
on pneumococcal antigen detection. Antigen can be detected as reliably in washed
sputum as in unwashed sputum.
Approximately 100 pneumococci per ml are required in vitro for a positive LA. Once
this threshold concentration was exceeded, antigen remained detectable in the pre-
sence of absence of penicillin for the entire 72 hours of the in vivo experiments. When
penicillin was added at a concentration below the threshold level antigen could not be
detected in the later phases of the experiment. Pneumococci isolated in concentrations
of more ,nun 190/ml are generally associated with clinical manifestations of infection.
Pneumococcal carriership in the upper respiratory tract seldom yields a positive anti-
gen result, because the number of pneumococci present are below the threshold level.
The amount of pneumococcal antigen present in the upper respiratory tract probably
does not influence antigen detection in sputum specimens.
Detectable antigen found in oropharyngeal secretions probably originates from the
lower respiratory tract and is suggestive of pneumococcal infection. In patients with
community-acquired pneumonia, oropharyngeal sampling may be an additional and
simple method for diagnosing pneumococcal aetiology.
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